Mori Memorial Foundation’s GPCI-2021 Report: COVID-19 Creates Challenges and Opportunities for Cities
TOKYO--(BUSINESS WIRE)--London, New York, Tokyo, Paris and Singapore once again emerged in that order as…
5 years ago
Advanced Energy’s 4100T optical fiber thermometer improves temperature accuracy and control in advanced semiconductor processes
With better measurement accuracy and higher read rate, the 4100T multi-channel, non-contact optical fiber thermometer…
5 years ago
CIFI’s ESG rating further upgraded to ‘BBB’ by MSCI
HONG KONG SAR - Media OutReach - 24 November 2021 - CIFI Holdings (Group) Co. Ltd. ("CIFI" or the…
5 years ago
Best’s Market Segment Report: AM Best Maintains Stable Outlook on Taiwan’s Non-Life Insurance Market
HONG KONG--(BUSINESS WIRE)--#insurance--AM Best is maintaining a stable market segment outlook on Taiwan’s non-life insurance…
5 years ago
VeriSilicon Image Signal Processor IP Achieved ISO 26262 Automotive Functional Safety Certification
The awarded certificate accelerates VeriSilicon’s strategic deployment in autonomous driving and the automotive segment in…
5 years ago
DHL Supply Chain is entrusted by GE Healthcare Japan with logistics operations to optimize healthcare service parts logistics
DHL Supply Chain opens five new logistics centers in Japan to meet the increasing demand…
5 years ago
Hagens Berman: Sun and Ranbaxy Facing January Trial as Federal Judge Denies Summary Judgment in Generic Drug Overpricing Lawsuit
Attorneys will take antitrust case to trial in January 2022 BOSTON--(BUSINESS WIRE)--#antitrust--Yesterday, a federal judge…
5 years ago
Takeda’s LIVTENCITYTM (maribavir) Approved by U.S. FDA as the First and Only Treatment for People Ages 12 and Older with Post-Transplant Cytomegalovirus (CMV), Refractory (With or Without Genotypic Resistance) to Conventional Antiviral Therapies
- In the Phase 3 SOLSTICE study, more than twice the proportion of adult transplant…
5 years ago
EBR Systems Raises AU$110M in Initial Public Offering on the Australian Securities Exchange (ASX)
EBR Systems’ WiSE™ CRT System is world’s first and only wireless endocardial (inside the heart)…
5 years ago
BeiGene Announces Approval of BRUKINSA (zanubrutinib) in the European Union for Treatment of Adults with Waldenström’s Macroglobulinemia
EU approval follows recent approvals for BRUKINSA including U.S., China, Brazil, and Canada The approval…
5 years ago